Nicotine transdermal patch
Sponsors
National Institute on Drug Abuse (NIDA), University of Texas at Austin, Yale University, James BOYD MD, Pierre Fabre Medicament
Conditions
Chemotherapy-induced Peripheral NeuropathyMajor Depressive Disorder (MDD)Mild Cognitive ImpairmentNeuropathic PainNeuropathyNicotine DependenceParkinson's DiseasePeripheral Neuropathy
Early Phase 1
Phase 1
Phase 2
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
CompletedNCT00124683
Start: 2001-09-30End: 2007-05-31Updated: 2017-01-12
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
NCT01560754
Start: 2012-10-31End: 2016-12-31Target: 160Updated: 2015-09-29
Nicotine Patch Safety Study
CompletedNCT01655082
Start: 2012-08-31End: 2012-10-31Updated: 2012-12-11
Memory Improvement Through Nicotine Dosing (MIND) Study
CompletedNCT02720445
Start: 2017-02-22End: 2025-09-16Updated: 2026-09-17
Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy
TerminatedNCT04468230
Start: 2020-07-31End: 2022-05-31Updated: 2023-11-08